|
|
Article: Higher-concentration olopatadine yields superior activity
- Article from:
- Ophthalmology Times
- Article date:
- February 15, 2007
- Author:
CopyrightCopyright Advanstar Communications, Inc. Feb 15, 2007. Provided by ProQuest LLC. (Hide copyright information)
|
New formulation
CAC study finds drug more effective for preventing itching, redness
Reviewed by Ernest W. Kornmehl, MD
Maui, HI-Results of a double-masked, randomized, placebo-controlled study demonstrated olopatadine 0.2% (Pataday, Alcon Laboratories) was more effective tor preventing allergen-induced ocular itching and redness than epinastine 0.05% (Elestat, Inspire Pharmaceutical s and Allergan). In addition, the new higher-concentration formulation of olopatadine was more comfortable than epinastine, reported Francis S. Mah, MD, here at the annual meeting of the Western Society of Allergy, Asthma & Immunology.
Dr. Mah was one of the investigators in the 7-week single-center study ...